Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Influenza: Page 2
Virax introduces rapid test kit for RSV, influenza A/B, COVID-19
By
LabPulse.com staff writers
Virax Biolabs announced the distribution of a rapid antigen test kit capable of detecting when individuals have been infected with RSV, Influenza A/B, or COVID-19.
November 3, 2022
University of Illinois spinout Shield T3 launches saliva-based PCR test for COVID, flu, RSV
By
LabPulse.com staff writers
Shield T3, a spinout of the University of Illinois, will offer a triple-virus PCR test kit, in anticipation of increased cases of COVID-19, flu, and RSV this winter.
October 25, 2022
Walgreens Flu Index shows 2022-2023 season exhibiting tenfold increase over last year
By
LabPulse.com staff writers
The Walgreens Flu Index indicates that flu activity this year is more than 10 times higher than in the previous year and has doubled over the past two weeks.
October 24, 2022
DiaSorin developing point-of-care molecular test for SARS-CoV-2, influenza under BARDA contract
By
LabPulse.com staff writers
DiaSorin will develop, verify, and clinically validate a point-of-care instrument and an initial combination test for SARS-CoV-2 and influenza A and B.
October 7, 2022
Siemens releases tests for seasonal respiratory pathogens
By
LabPulse.com staff writers
The CE-marked FTD SARS-CoV-2/FluA/FluB/HRSV PCR assay is available to laboratories, while the Clinitest Rapid COVID-19 + Influenza Antigen Test is used at the point of care.
September 14, 2022
MagBio Genomics secures 510(k), CE Mark approval
By
LabPulse.com staff writers
A guanidine-free molecular transport medium, the MagXtract Collection Tube eliminates the risk of accidentally creating cyanide gas during cleaning, directly lyses cells during transport, inactivates pathogens, and maintains ambient temperature stability of RNA samples for up to eight days, thus eliminating the need for cold storage and shipping, the firm said.
September 11, 2022
Cue Health requests FDA de novo clearance for at-home flu test
By
LabPulse.com staff writers
Clearance would permit the test to be used at home and elsewhere at the point-of-care (POC).
September 1, 2022
Hologic launches respiratory assays in Europe
By
LabPulse.com staff writers
Both products are compliant with the European In Vitro Diagnostic Medical Device Directive (IVDD) and are being made available in time for the Northern Hemisphere's respiratory viral season, the firm said.
July 10, 2022
BD nabs CE Mark for respiratory viral panel
By
LabPulse.com staff writers
The panel, a molecular diagnostic combination test for SARS-CoV-2, influenza A + B, and respiratory syncytial virus (RSV), uses a nasal swab or nasopharyngeal swab sample.
June 30, 2022
Seegene secures EU approval for SARS-CoV-2 assay
By
LabPulse.com staff writers
The clearance will allow Seegene to market the assay to small hospitals, local clinics, and public health centers for identification of COVID-19, influenza A and B, and respiratory syncytial virus (RSV).
June 28, 2022
FDA issues EUA for Labcorp NGS test to detect SARS-CoV-2 strains
By
LabPulse.com staff writers
The SARS-CoV-2 virus has mutated over time, resulting in multiple strains, also known as lineages.
June 12, 2022
CorDX obtains CE Mark for test for COVID-19, flu A/B, RSV
By
LabPulse.com staff writers
"As COVID-19 infection prevention measures relax globally, COVID and other viral infections are projected to rise," CorDx founder and CEO Jeff Yufeng Li said in a statement.
June 2, 2022
Previous Page
Page 2 of 7
Next Page